Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC

NCT02724332 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Rapamycin

Interventions

DRUG: Rapamycin

Sponsor

Eastern Hepatobiliary Surgery Hospital